BioCryst's total assets for Q3 2024 were $491.25M, an increase of 3.99% from the previous quarter. BCRX total liabilities were $959.82M for the fiscal quarter, a 1.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.